CALPREST— 510(k) K130945

Substantially Equivalent

Eurospital S.P.A.

FDA 510(k) clearance K130945 for CALPREST, Substantially Equivalent on 2014-01-16. Applicant: Eurospital S.P.A..

Clearance details

Applicant: Eurospital S.P.A.
Product code: Code NXO
Advisory panel: Immunology
Date received: 2013-04-04
Decision date: 2014-01-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Woodstock, GA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.